The Boeing BA

Reference table

1. What the business is, and the segment table the vendor destroyed

Chief executive Robert K. Ortberg; 182,000 employees; NYSE-listed; CIK 0000012927; reporting in USD (no currency-mixing trap).

Three reportable segments. The vendor's seg_prod supplies ONE of them for fiscal 2025.

The vendor's fiscal-2025 seg_prod entry contains a single line — Commercial Airplanes Segment $41,494,000,000 — against total revenue of $89.463B. Defense, Space & Security and Global Services, together 53.8% of the company, are simply absent. The fiscal-2024 entry has all three. This is the MTZ-class vanished-segment defect and it is the worst single omission in this batch. We source the segment table from the 10-K instead:

Read the Global Services line carefully, because it is the single most important number in this file. The 10-K states: "BGS earnings from operations in 2025 increased by $9,856 million compared with 2024, primarily due to a 2025 gain on the Digital Aviation Solutions Divestiture of $9,566 million." Strip the gain and Global Services earned roughly $3.9B on $20.9B of revenue — an 18.7% margin, which is a very good business — and total company earnings from operations were roughly MINUS $5.3 billion.

Commercial Airplanes lost $7,079M in 2025 on $41,494M of revenue. It has lost money every year in this file. In the June 2026 quarter it lost $322M on $11,751M — much better, but still negative. The entire equity case is that line crossing zero.

Geography — and seg_geo double-counts. The fiscal-2025 entry contains both a Non-US line of $41,380M and the six regional lines that compose it (Africa $1,625M, Asia other than China $16,466M, Canada $1,781M, Europe $11,419M, Latin America $1,479M, Middle East $7,023M = $39,793M), plus United States $48,083M. Summing every field gives $129.26B against revenue of $89.463B — a 1.44x over-sum of the XOM class. The correct read is United States $48,083M + Non-US $41,380M = $89,463M, an exact tie, with the six regions being components of the Non-US subtotal and $1,587M unallocated among them.

China is the disclosure that vanished. A separate CHINA line appears in Boeing's geographic table for 2018 ($13,764M — 18.8% of revenue), 2019 ($5,684M) and 2020 ($1,803M), and does not appear at all for 2021 through 2025. The knowledge base carries a 2019 claim that "China is Boeing's second-biggest market — hundreds of millions fly Boeing domestically — so Boeing is structurally exposed to US-China political friction." That exposure is now either immaterial or folded into "Asia other than China", and either way Boeing has stopped telling shareholders about the world's largest aviation growth market. We flag this as a disclosure gap, not a vendor defect.

Backlog — the strongest number Boeing has:

$715.3 billion is 8.0x fiscal-2025 revenue and 7.3x the FY2026 consensus. The 10-Q states approximately 21% converts to revenue through 2027 and 62% through 2030, with the explicit caveat that "we may experience reductions to backlog and/or significant order cancellations due to various factors including delivery delays, production disruptions and delays to entry into service of the 777X, 737-7 and/or 737-10." There is no field in the vendor payload that contains this or anything like it.

2. The production recovery, and the two programmes that can still break it

The 737, from the 10-K, in the company's own words:

> "The 737 production rate was significantly disrupted in 2024 because of the 737-9 door plug accident and the IAM labor strike. Throughout 2025, the rate recovered from below 38 aircraft per month at the beginning of the year to 42 per month during the fourth quarter."

> "These plans include increasing the 737 production rate to 47 per month in 2026."

The 777X, also from the 10-K, and this is the risk:

> "In the third quarter of 2025, we reassessed the anticipated timing to complete FAA certification flight testing and delayed first delivery of the 777-9 to 2027."

> "During recent inspections on the 777X, we identified a potential durability issue on the engine. We are continuing certification flight testing as we work with the supplier to determine root cause and corrective action."

The 767: "We are currently targeting a production rate of approximately three aircraft per month. We expect to complete production of the 767 commercial program by 2027."

Why this matters more for Boeing than for any other name in this batch: program accounting. Boeing recognises commercial-aircraft costs across an accounting quantity of units, not per delivery. When the estimated total cost of a programme exceeds its estimated total revenue, the whole shortfall is recognised at once as a reach-forward loss. The 777X and 767 programmes produced $4,079M of reach-forward losses in 2024, and the 10-K reports "higher combined 777X and 767 reach-forward losses recorded during 2025 compared to 2024." The September 2025 quarter's minus $7.47 EPS — against a minus $5.16 estimate — is what that looks like when it lands. A single re-estimate can erase a year of recovery in one line, and the engine durability issue is precisely the kind of event that triggers one.

The quarterly record, using the 10-Q's figures where they differ from the vendor's:

Two quarters of positive operating earnings, and still a net loss, because interest and debt expense is running at $600M a quarter. The 10-Q's own bridge for the June quarter: earnings from operations $156M, other income $79M, interest and debt expense minus $600M, loss before tax minus $365M, tax expense minus $63M, net loss attributable to shareholders minus $444M. Boeing's operating recovery is currently being consumed entirely by its interest bill — which is precisely why the $8.2B of debt reduction in six months matters, and why interest expense fell $202M year on year in the half "primarily as a result of lower debt balances."

Cost of sales is going the wrong way. The 10-Q: 90.2% of revenue in the June quarter against 89.3% a year earlier, and 89.4% for the half against 88.5% — a 90 basis point deterioration on both measures, "primarily due to higher revenues at BDS and BCA."

Research and development was $1,824M in the first half, up $70M, with Commercial Airplanes at $1,200M of it. That is the number that would rise sharply if Boeing ever answered the clean-sheet-aircraft criticism, and it has not.

3. Balance sheet — the largest correction in this batch

Correction 1 — netDebt is 68% too high, through two compounding errors. The vendor reports $43,512M. It computes total debt ($54,433M) less cash and equivalents ($10,921M) only, ignoring $18,479M of short-term and other investments that sit on the face of Boeing's own balance sheet. That alone takes it to $25,033M at 2025-12-31. Then the balance sheet is six months stale, across a period in which the 10-Q states total debt fell from $54.1B to $45.9B. Correcting both:

> Total debt at 2026-06-30 $45.9B (10-Q MD&A: "the total debt balance was $45.9 billion, down from $54.1 billion at December 31, 2025")

> − cash $7.239B − short-term and other investments $12.783B

> = corrected net debt $25.878B

The vendor reports net debt of $43.512B; the filing supports $25.878B; we use $25.878B. That is a $17.63B, 68% overstatement — proportionally the largest balance-sheet error in this batch.

Correction 2 — $5,750M of preferred stock is in no vendor field. The 10-Q balance sheet carries "Mandatory convertible preferred stock, 6.00% Series A, par value $1.00 – 20,000,000 shares authorized; 5,750,000 shares issued; aggregate liquidation preference $5,750" million. It ranks ahead of the common, pays roughly $345M a year, and appears in no enterprise-value calculation the vendor performs. We add it.

The rebuilt enterprise value:

> Market cap $187.428B (789.8M shares × $237.14)

> + total debt $45.900B (10-Q, 2026-06-30)

> + preferred liquidation preference $5.750B

> + noncontrolling interests $0.015B

> − cash and short-term investments $20.022B

> = corrected enterprise value $219.071B (or $213.321B excluding the preferred)

The vendor reports $226.079B. Note also that the vendor's own EV does not reconcile to its own net debt: $226.079B less market cap $187.428B implies net debt of $38.651B, not the $43.512B in km_ttm.netDebtTTM. The vendor file is internally inconsistent by $4.86B and we report that rather than choosing one.

Correction 3 — every trailing multiple built on EBITDA or earnings is rejected. evToEBITDATTM of 32.53x and netDebtToEBITDATTM of 5.561x rest on a trailing EBITDA that is only positive because of the divestiture gain. Trailing operating income is minus $5.083B and interestCoverageRatioTTM is minus 1.979x. priceToEarningsDilutedRatioTTM of 102.7x rests on trailing diluted EPS of $2.31 which is entirely the Q4 2025 gain. priceToFreeCashFlowRatioTTM of 765x and evToFreeCashFlowTTM of 922.8x are arithmetically correct and analytically useless — they simply mean free cash flow is near zero. None of these figures appears in any conclusion in this dive.

Two balance-sheet items that carry the real risk.

Inventories are $88,388M — 94% of a full year's revenue, up $3,709M in six months. The 10-Q discloses deferred production costs inside this for both the 737 and 787 programmes. Under program accounting, inventory is where unrecovered cost accumulates until either a delivery or a reach-forward loss releases it.

Advances and progress billings are $64,059M, up $4,655M in six months. This is customer money Boeing holds against undelivered aircraft. It is why the current ratio of 1.138 understates the working-capital position in one sense and overstates the balance-sheet strength in another: the cash has been received and largely spent, and the obligation is to deliver aircraft.

Total equity is $6,115M on $165,870M of assets — a 3.7% equity ratio. It was negative $3,914M at 2024-12-31 and negative $17,228M at 2023-12-31. priceToBookRatioTTM of 30.75x, returnOnEquityTTM of 104.8% and debtToEquityRatioTTM of 7.523x are all arithmetically correct and all economically meaningless — they are what happens when a company earns a positive number on a near-zero denominator that was recently negative. This is the ABBV mechanism and we reject all three as lenses. returnOnInvestedCapitalTTM of minus 7.72% is the honest measure and it is negative.

4. Cash flow

The cash-flow turn is the most important trend in this file and it is enormous in absolute terms: from minus $14.4B of free cash flow in 2024 to roughly breakeven on the trailing twelve months — a swing of about $14.6 billion. The 10-K attributes the 2025 investing inflow to "an increase in Proceeds from dispositions of $10.5 billion" — the Jeppesen sale — so the cash improvement is partly asset sale and partly operations.

Capital expenditure is rising: $1.222B → $1.527B → $2.318B → $2.942B, which is what a rate ramp to 47 per month requires and is the correct thing to be spending on.

There is no dividend. The vendor reports lastDividend: 8.22 alongside dividendPerShareTTM: 0 and dividendYieldTTM: 0. The $8.22 is a stale pre-2020 annual figure; Boeing suspended its dividend in 2020 and has not reinstated it. The payload contradicts itself in adjacent fields and we use the zero.

Buybacks are effectively zero ($34M in 2025) and the share count has risen 39% since 2020 — 569.0M diluted in 2020 to 791.0M in the June 2026 quarter. There is no shareholder yield here of any kind, and the $5,750M mandatory convertible preferred will add further common shares on conversion.

5. Valuation — priced in or room?

At $237.14 (market cap $187.428B, corrected enterprise value $219.071B):

Three things about this table.

First, the price is being set on FY2028 and beyond. FY2026 consensus EPS is negative. FY2027's $4.005 puts the stock at 59.2x. You have to reach FY2029 before the multiple is ordinary, and FY2029 rests on 11 analysts three and a half years out.

Second, the FY2028 dispersion is the widest of any estimate line in this batch: $5.118 to $12.617, a factor of 2.5. At the low the stock is 46x; at the high it is 18.8x. That spread is the honest statement of how uncertain the recovery path is, and it is far more informative than the $7.925 mean.

Third, est.ebitdaAvg is NEGATIVE in every forward year while niAvg is positive — arithmetically impossible, and REJECTED. FY2028 shows ebitdaAvg of minus $319.5M against netIncomeAvg of $6,265M. A company cannot have negative EBITDA and $6.3B of net income. Worse, the ratios are fixed: ebitdaAvg / revenueAvg = minus 0.2604% and ebitAvg / revenueAvg = minus 3.010% in every one of the eight years in the file, to four significant figures. This is the documented fabrication signature and it hits both the "negative EBITDA" and the "fixed ratio" detectors. Per the data contract, all forward valuation runs on epsAvg and revenueAvg.

Peer context. The vendor peer set is a defence-and-industrial grab-bag: Eaton, Union Pacific and Honeywell are not Boeing comparables, and Firefly Aerospace ($3.8B) and Voyager Technologies ($2.0B) are not comparable to a $187B company. The defensible names are RTX ($293.5B), Lockheed Martin ($136.0B), General Dynamics ($104.4B), Northrop Grumman ($78.4B) and L3Harris ($53.1B) — all of which are profitable defence primes, and none of which has Boeing's commercial-aerospace exposure. Boeing's true comparable, Airbus, is not in the payload. No peer multiples are supplied, so no peer-multiple comparison is drawn.

5a. What today's price assumes (the inversion)

At $237.14 — 59.2x FY2027 consensus and 29.9x FY2028 — the price embeds:

• The 737 rate reaches 47 per month in 2026 and holds. (Company plan, stated in the 10-K, half-weighted as management framing.) It was below 38 at the start of 2025 and 42 in the fourth quarter. This is the single most observable claim in the dive and it is checkable monthly.
• Commercial Airplanes stops losing money by roughly FY2027. (Our derivation.) BCA lost $7,079M in 2025 and $885M in the first half of 2026. For consensus EPS to reach $4.005 in FY2027 on 800M-plus shares — roughly $3.3B of net income after a ~$2.4B interest bill and tax — segment earnings must swing by something like $5-6B from the 2025 base. Most of that has to come from BCA.
• No further material reach-forward loss on the 777X. (Our framing; the risk is the 10-K's own disclosure.) First delivery is already 2027 and the 10-K discloses a "potential durability issue on the engine" under investigation with the supplier. This is the most fragile assumption in the price, because reach-forward losses are lumpy, unforecastable and have twice cost multiple billions in a single quarter — most recently minus $7.47 EPS in September 2025.
• Revenue reaches $122.650B by FY2028, a 37% increase off 2025. (Consensus; 20 analysts.) The backlog supports it arithmetically — 21% of $715.3B converts through 2027 — but the 10-Q attaches the explicit caveat of "significant uncertainty regarding the timing" and names the 777X, 737-7 and 737-10 as the specific delay risks.
• The market keeps paying roughly 30x on FY2028 or 20x on FY2029 throughout. (Our number.) At 25x FY2028E the stock is $198; at 35x it is $277. The multiple, applied to an earnings number three years out with a 2.5x consensus spread, is where essentially all of the variance sits.

5b. The return bridge (why the multiple moves)

Boeing has no dividend, no buyback and a rising share count, so shareholder yield is negative and the entire return is earnings growth plus multiple change. Expected return to end-FY2027 decomposes as: EPS going from negative in FY2026 to $4.005 in FY2027 to $7.925 in FY2028 (not a percentage — a sign change) + multiple COMPRESSION from 29.9x on FY2028 to roughly 20x on the then-forward year + dilution of perhaps 2-4% from the mandatory convertible.

This is a different return structure from every other name in this batch, and it should be stated as such: the return does not come from earnings growth on a stable multiple. It comes from a loss-making company becoming a profitable one, during which the multiple necessarily collapses from infinity toward normal. Our base case therefore assumes large multiple compression — from 29.9x FY2028E today to roughly 20x by the time FY2029 is the forward year — and that compression is not a bearish assumption. It is what happens mechanically when the E in P/E arrives.

What that means practically: the base case return of +3.3% is the residual after the compression eats the earnings recovery. If instead the market pays 25x FY2028E, the stock is $198 — 16.5% below today's price even with consensus earnings delivered in full. If it pays 35x, the stock is $277. The bull case at $315 is 25x the FY2028 consensus HIGH of $12.617 — an earnings beat AND a multiple above our base. The bear case at $150 holds today's ~29x multiple against the FY2028 consensus LOW of $5.118, i.e. no de-rating at all, just a slower recovery. That construction is deliberate: the bear case does not require the market to lose faith, only for the timeline to slip.

5c. Variant perception (where we differ, what would surprise)

• We differ from the street on the balance sheet, and it is the largest single correction in this batch. Every screen shows Boeing with $43.512B of net debt. The 10-Q supports $25.878B — 68% lower — once the $12.783B of short-term investments is counted and the six months of $8.2B debt reduction is picked up. That is not a rounding error on a company with 3.7% equity and negative interest coverage; it materially changes how close to the edge Boeing is, and it is the main reason our risk score is 8 rather than 9.
• We differ from a naive filing read on the 2025 earnings, in the opposite direction. The 10-K's reported earnings from operations of $4,281M for 2025 looks like the year Boeing turned profitable. It contains a $9,566M gain on the Digital Aviation Solutions divestiture. Ex-gain, operations lost roughly $5.3 billion — and the vendor's operatingIncome of minus $5,416M is, unusually, the cleaner of the two figures. We report both and use the ex-gain number for every trend conclusion. Watchable number: Global Services segment earnings in FY2026, which must land near $3.9B rather than $13.5B for the comparison to be honest, and which will now be smaller still because Jeppesen has been sold.
• We differ on how to read the Jeppesen sale, and the knowledge base gives us the other side of the trade. An independent claim dated 2025-10-15 describes the buyer's view: "Bought Boeing's Jeppesen avionics business for ~$10.5B — a gem asset with ~25% margins that can be run like a software company toward 50%+ margins." Boeing sold its highest-quality, highest-margin, most software-like asset to fix a balance sheet. That was probably necessary. It was not value-creating, and the $9,566M gain that made 2025 look profitable is the accounting residue of it.
• We do not differ from the street on direction and we say so. 37 buy, 13 hold, 5 sell, consensus $274.17, with the LOW published target at $250, above the current price. Our $245 is 10.6% below the street mean and 2.0% below the street's most bearish published target. We are more cautious than the entire published sell-side, which is a position worth stating plainly rather than dressing up: we think the recovery is real and the price already contains it.
• Positive surprise that would force a re-rate: the 737 rate confirmed at 47 per month with Commercial Airplanes at or near breakeven in a quarter; free cash flow clearly positive for a full half; a 777-9 certification milestone with the engine issue resolved; or a China order re-emerging as a disclosed geographic line, which would restore a market worth $13.8B in 2018.
• Negative surprise that would break the thesis: a new reach-forward loss on the 777X of $2B or more; the 737 rate stalling below 47; an inventory charge against the $88.4B balance; or a further slip in 777-9 first delivery beyond 2027. At 30x FY2028 earnings with negative trailing operating income, none of these is absorbed by the valuation.

Synthos fair values

All three anchors are multiples of the FY2028 consensus EPS distribution (mean $7.925, low $5.118, high $12.617, 13 analysts), cross-checked against FY2029E of $12.122 and against enterprise value to forward sales.

• Bear ~$150 — 29.3x the FY2028 consensus LOW of $5.118, i.e. today's multiple applied to a slower recovery with no de-rating at all. Cross-check: corrected EV of $138.4B on FY2027E revenue of $112.335B is 1.23x sales; roughly the price this stock traded at in mid-2025. The scenario: the 737 rate stalls near 42, a further 777X reach-forward loss lands, and FY2028 earnings arrive in FY2030 instead. −36.7%.
• Base ~$245 — 30.9x the FY2028 consensus MEAN of $7.925. Cross-check: 20.2x FY2029E of $12.122; corrected EV of $226.6B on FY2027E revenue of $112.335B is 2.02x sales; and 0.32x total backlog. Sensitivity, stated openly: 25x FY2028E gives $198, sixteen percent BELOW spot, and 35x gives $277, above the street's median. The whole answer lives in a 25-35x band on a number with a 2.5x consensus spread, and we claim no precision at all beyond that. The scenario: the rate ramp lands roughly on plan, Commercial Airplanes crosses breakeven in FY2027, no new mega-charge appears, and the multiple compresses toward twenty times as real earnings arrive. +3.3%.
• Bull ~$315 — 25x the FY2028 consensus HIGH of $12.617. Cross-check: 26.0x FY2029E; above the street's $300 high target, which is disclosed as an outlier position. The scenario: 47 per month is reached and exceeded, the 777-9 certifies cleanly in 2027, defence swings from a $128M loss to a normal margin, the backlog converts faster than the 21%-by-2027 guide, and Boeing re-rates as a returning cash compounder. +32.8%.

Base is 3.3% above spot; asymmetry roughly 0.89:1 — slightly NEGATIVE (36.7% down, 32.8% up). This is the only name in this batch where the asymmetry runs against the buyer, and it is the central reason for the verdict. We are not saying the recovery fails. We are saying you are being offered less upside than downside for participating in it at this price.

6. Knowledge base — 35 hits, four named independent speakers, genuinely two-sided

Raw hits: 35 (19 entity, 16 text). Used: 17. Discarded: 18. Searches covered Boeing, Airbus and Ortberg across all 51,928 distilled claims.

Homograph check — passed, and worth stating. Several claims carry the entity tag "BA". We verified each against its thesis text: all are unambiguously about The Boeing Company (Max crisis, duopoly, defence primes, China order books). No collision with the ordinary-language use of the letters, and no collision with British Airways, which does not appear. This is the check the short-symbol rule exists for and it comes back clean.

Discards, by reason:

• SCALE METAPHOR / INCIDENTAL EXAMPLE — 8 claims. "A 1-gigawatt AI factory costs ~$60B annually (Boeing-scale revenue)"; "Branson launched Virgin Atlantic with near-zero via a leased Boeing 747"; "the best firms exploit their own mistakes and pivot (Nokia, Tiffany, Boeing, Viagra)"; "like Boeing not a plane"; "Architectural innovation... lets newcomers like Amazon or Boeing win"; and three others. None is a claim about the security.
• ABOUT A DIFFERENT COMPANY — 5 claims. Two are about GE/CFM engine economics with Boeing as the customer; one is about Ryanair's aircraft purchasing; one is about Motorola Solutions with Airbus as a competitor; one is an Airbus-positive claim ("Calhoun is 'the best CEO Airbus could ask for'") tagged to EADSY. The Airbus claims are relevant colour and are noted, but they are not Boeing claims.
• MACRO DATA ARTEFACT — 2 claims. The 2024 Boeing strike as a payrolls distortion. Not about the equity.
• SUPERSEDED — 3 claims. Pre-2020 claims about China as Boeing's second-biggest market. They are superseded by Boeing's own disclosure, which stopped reporting a separate CHINA line after 2020. We note the supersession as itself informative and do not count them in the lane.

The seventeen claims used, grouped by what they argue.

The duopoly and barrier-to-entry case — five claims, three sources, spanning 2019 to 2023:

> 2019-05-01 · bullish · conviction 78 · principle · channel: chinatalk · no named speaker

> "Jetliners are 'apex technology' — engineering, avionics, software, safety, project-management barriers so high that Boeing/Airbus hold a durable global duopoly."

> 2021-10-05 · neutral · conviction 65 · thesis · channel: dwarkesh · no named speaker

> "Wide-body commercial planes are a hard two-player duopoly (Boeing, Airbus); China's failure to catch up shows the capital/supply-chain barrier to entry."

> 2023-11-07 · bullish · conviction 72 · principle · speaker: John Ostrower · role: independent · channel: business_breakdowns

> "Entering commercial aircraft is one of the hardest things in business and requires sovereign backing — Bombardier's technically superior C-Series and Mitsubishi's regional jet both failed, absorbed by Airbus or shelved."

> 2023-11-07 · neutral · conviction 75 · principle · speaker: John Ostrower · role: independent

> "Boeing and Airbus are best understood not as discrete companies but as extensions of their national patrons — instruments of US and EU soft power, backed by state departments in their sales campaigns."

Plus a 2019 claim that Boeing and Airbus "protect their moat by transferring only near-obsolescent technology to Chinese co-production partners", and a 2019 COMAC claim that China "still has a 'fair way to go' to break the duopoly."

This is the strongest structural evidence in the file and it is genuinely independent — three unrelated channels and one named aviation journalist converging across seven years. It is also the reason the risk score is 8 rather than 9: a company whose worst realistic outcome is state support is not a company that goes to zero.

The bear case — four claims, two with named independent speakers:

> 2024-12-30 · bearish · conviction 72 · thesis · speaker: Richard Abulafia · role: independent · channel: odd_lots

> "Boeing hasn't launched a clean-sheet aircraft since 2004 and plans none for another decade — a glide slope to oblivion as aging engineers leave and skills erode."

> 2023-11-07 · bearish · conviction 55 · thesis · speaker: John Ostrower · role: independent

> "Despite the Max crisis and leadership change, Boeing's fundamental strategy hasn't changed — still built for growth/replacement measured on cash generation; the McDonnell Douglas-era financialization remains the unresolved root problem."

> 2025-10-16 · bearish · conviction 70 · thesis · channel: invest_like_the_best · no named speaker

> "America's apex manufacturers — Boeing, Intel, Detroit/Tesla — are mostly declining, evidence the US isn't relearning hard manufacturing."

> 2026-04-22 · bearish · conviction 66 · thesis · speaker: Jim Bianco · skill 0.8

> "Raytheon, General Dynamics and Boeing are the past; cheap-drone warfare demands new tech-oriented defense, so the primes are correcting and underperforming despite the conflict — a bear's trend."

The Abulafia claim is the most specific and the most testable bear argument on this name anywhere in the knowledge base, and nothing in the 2025 10-K contradicts it. Boeing's first-half 2026 Commercial Airplanes research and development was $1,200M — a rate consistent with derivative work and certification, not with a clean-sheet programme. A 2024-05-12 claim rating Boeing default as "a decent risk scenario" is noted and is now clearly wrong on the balance sheet as it stands today; we record the miss.

The order-book and policy case — five claims, three of them 2026:

> 2025-05-17 · bullish · conviction 60 · fact · channel: all_in — "Boeing landed large Gulf orders (~$96B Qatar, ~$160B Saudi) for next-generation planes."

> 2026-01-09 · bullish · conviction 60 · fact · channel: all_in — "Trade deals bundle large Boeing aircraft purchases (50–100 planes); Commerce actively brokers US export sales."

> 2026-05-14 · bullish · conviction 62 · fact · speaker: Graham Allison — bets a summit "yields business deals of roughly $1 trillion, including big China buys of Boeing aircraft."

> 2026-05-15 · bullish · conviction 62 · thesis · speaker: Mark Benioff · channel: all_in — US chief executives "will return with big China order books — Boeing planes".

> 2026-04-22 · bullish · conviction 48 · thesis · speaker: Arthur Hayes · skill 1.2 — war financing expands weapons production at "Boeing, Raytheon, Northrop Grumman."

Two of these five are corporate-executive voices speaking about political access rather than about Boeing's operations, and the Benioff claim in particular is a chief executive of an unrelated company forecasting order books. We weight the whole political-order cluster LOW — it is directionally interesting, it corroborates the $33.1B of backlog growth in six months, and it is unfalsifiable on any timeline we can grade. Against it stand two 2025 claims from a single channel arguing the opposite — that "US defense and aircraft exports are procured by foreign governments who will now buy elsewhere; EU rearmament will exclude US systems."

Two further claims used as colour: the aftermarket economics claim ("parts sell to airlines at 3-4x the price sold to Boeing"), which explains why Global Services carries an 18.7% clean margin; and the Jeppesen buyer's claim ("a gem asset with ~25% margins... can be run like a software company toward 50%+ margins"), which is the other side of the transaction that produced Boeing's $9,566M gain.

One claim we flag as a governance observation without endorsing it:

> 2025-11-02 · bearish · conviction 82 · principle · channel: nassim_taleb · no named speaker

> "Regulatory capture is structural — Monsanto wrote EPA documents, Boeing controls the FAA — because underpaid agency staff angle for industry jobs."

We record it because the highest-conviction bearish claim in the lane is about the regulator relationship, and because the 10-K's own disclosure — that Boeing must "follow the lead of the FAA" on the 777X, 737-7 and 737-10 certification timelines, all of which have slipped — is evidence that the relationship currently constrains Boeing rather than serving it.

Net conviction: mixed. Breadth 17, with four named independent speakers and a clear structural-bull versus execution-bear split. No management voice appears in the lane at all. The order-book cluster is weighted low with the frame disclosed. This is the best-sourced lane in this batch and it still does not resolve to a direction — which supports Watch rather than contradicting it.

7. Data integrity — what we rejected from the vendor file and why

Eleven findings. BA has the largest proportional balance-sheet error and the largest segment omission in this batch.

1. netDebt of $43,512M is 68% too high — REJECTED and rebuilt. Two compounding errors: it ignores $18,479M of short-term and other investments on Boeing's own balance sheet, and it carries a 2025-12-31 balance sheet through a half-year in which the 10-Q states total debt fell from $54.1B to $45.9B. The vendor reports $43,512M; the 10-Q supports $25,878M ($45.9B debt less $7,239M cash less $12,783M short-term investments); we use $25,878M.

2. seg_prod for fiscal 2025 contains ONE segment out of three — REJECTED and replaced from the 10-K. The entry lists only Commercial Airplanes Segment $41,494M against total revenue of $89,463M. Defense, Space & Security ($27,234M) and Global Services ($20,923M) — together 53.8% of the company — are absent. The fiscal-2024 entry has all three. This is the MTZ-class vanished-segment defect. All segment figures in this dive come from the 10-K's own table, which ties: $41,494M + $27,234M + $20,923M − $188M = $89,463M, exactly reported revenue.

3. seg_geo for fiscal 2025 double-counts by 1.44x — corrected. The entry contains both a Non-US subtotal of $41,380M and the six regional lines that compose it ($39,793M), plus United States $48,083M. Summing all eight fields gives $129.26B against $89.463B of revenue. The correct read is US $48,083M + Non-US $41,380M = $89,463M, an exact tie, with $1,587M unallocated among the named regions. We use the two-line read. Separately, a CHINA line appears for 2018-2020 and disappears entirely from 2021 onward — a real disclosure change, not a vendor defect, and one that removes an $13,764M (2018) revenue line from view.

4. FY2025 operating income differs between vendor and filing by $9,697M, and BOTH are informative — both reported. The 10-K's table gives earnings from operations of $4,281M for 2025; the vendor's operatingIncome is minus $5,416M. The bridge is the $9,566M gain on the Digital Aviation Solutions divestiture, which Boeing recognises inside Global Services segment earnings and therefore inside GAAP earnings from operations, and which the vendor excludes. Standing rule says the filing wins — but here the vendor's exclusion produces the cleaner operating figure. We report the filing's $4,281M as the GAAP number and use the ex-gain figure of roughly minus $5.3B for every trend conclusion, stating the reconciliation each time. The vendor's FY2024 (minus $10,824M) and FY2023 (minus $821M) figures agree with the filing's minus $10,707M and minus $773M to within 1%.

5. Trailing earnings, EBITDA, P/E, EV/EBITDA, price-to-free-cash-flow and interest coverage are all rejected as lenses. Trailing diluted EPS of $2.31 consists entirely of the Q4 2025 divestiture gain; priceToEarningsDilutedRatioTTM of 102.7x is a number about an asset sale. evToEBITDATTM of 32.53x and netDebtToEBITDATTM of 5.561x rest on the same gain. Trailing operating income is minus $5,083M and interestCoverageRatioTTM is minus 1.979x. priceToFreeCashFlowRatioTTM of 765x and evToFreeCashFlowTTM of 922.8x are arithmetically correct and mean only that free cash flow is near zero. None appears in any conclusion.

6. est.ebitdaAvg is NEGATIVE in every forward year while netIncomeAvg is positive — arithmetically impossible, REJECTED. FY2028 shows ebitdaAvg minus $319.5M against netIncomeAvg of $6,265M. The ratios are also fixed: ebitdaAvg / revenueAvg = minus 0.2604% and ebitAvg / revenueAvg = minus 3.010% in all eight years, to four significant figures. This trips two of the documented detectors simultaneously. All forward valuation runs on epsAvg and revenueAvg.

7. Book-equity metrics are meaningless — REJECTED as lenses. priceToBookRatioTTM and priceToFairValueTTM (both 30.75x), returnOnEquityTTM (104.8%) and debtToEquityRatioTTM (7.523x) all rest on total equity of $6,115M — 3.7% of assets, and negative $3,914M eighteen months ago and negative $17,228M in 2023. This is the ABBV mechanism. returnOnInvestedCapitalTTM of MINUS 7.72% is the honest measure. The vendor's own rating block scores Boeing 1 out of 5 on debt-to-equity, price-to-earnings, price-to-book and discounted cash flow, giving C / 2 overall — the lowest composite in this batch — while scoring 5 out of 5 on return on equity. A rating that simultaneously gives a company the worst possible debt score and the best possible equity-return score is measuring the same near-zero denominator twice, in opposite directions. We reject the composite.

8. The vendor file is internally inconsistent on enterprise value by $4.86B. enterpriseValueTTM of $226.079B less market cap of $187.428B implies net debt of $38.651B, against netDebtTTM of $43.512B in the same file. Neither is right; the corrected figure is $25.878B.

9. $5,750M of preferred stock is in no vendor field — added to enterprise value. The 10-Q balance sheet carries 5,750,000 shares of 6.00% Series A mandatory convertible preferred stock with an aggregate liquidation preference of $5,750 million. It ranks ahead of the common and costs roughly $345M a year. This is the off-balance-sheet-item class: an obligation with no vendor field. We add it, and report EV both with ($219.071B) and without ($213.321B) it.

10. lastDividend: 8.22 contradicts dividendPerShareTTM: 0 and dividendYieldTTM: 0 in the same payload. Boeing suspended its dividend in 2020 and has not reinstated it. The $8.22 is a stale pre-suspension annual figure. We use zero. Note also that dividendPayoutRatioTTM of 0.1417 is non-zero against a zero dividend — a third inconsistent field on the same subject.

11. Q2 2026 operating income differs by $78M — the filing is used. The vendor's inc_q shows $78M for the quarter ended 2026-06-30; the 10-Q's segment reconciliation shows $156M of earnings from operations for the same quarter (and $604M for the half, of which the vendor's Q1 figure of $448M is confirmed). Small, but the filing wins and we use $156M.

Share count — checked and verified clean. The 10-Q balance sheet gives 1,012,261,159 shares issued less 222,468,625 in treasury = 789,792,534 outstanding. Market cap of $187,428,341,800 divided by $237.14 gives 790,368,000 — agreement to within 0.07%. No share-class or partial-unit error. Diluted weighted-average shares of 791.0M are consistent. Note separately that this count has risen 39% since 2020 (569.0M), which is real dilution and not a defect.

quote.yearHigh/yearLow ($254.35 / $176.77) disagree with tech.hi52/lo52 ($252.15 / $179.12) by 0.9% and 1.3%. We use tech. Note that tech.max_dd_from_peak of −11.91% differs from pct_from_hi of −5.95% because peak is a six-year maximum (implying roughly $269) while hi52 is the 252-day maximum. Per the data contract this is a legitimate difference, not a defect.

Non-equity tripwire — checked and passed. BA is common stock, par value $5.00, NYSE-listed. Price $237.14 is not par-like; beta 1.205; there is no dividend at all, which is the opposite of a fixed-income-like instrument; volume 6.47M shares (~$1.53B of turnover); the 52-week band of $179.12 to $252.15 is a 41% range. This is common equity. Note that the company DOES have a preferred instrument outstanding, and a reader screening on "BA" should confirm they are not looking at the Series A mandatory convertible.

8. Technicals

• Price $237.14. −5.95% from the 52-week high of $252.15; +32.4% above the low of $179.12. Position within the annual range: 79th percentile — the top quintile.
• Moving averages, both below and both supportive: +8.0% above a 50-day average of $219.48 and +8.5% above a 200-day of $218.59, with the 50-day marginally above the 200-day. This is the only clean uptrend configuration in this batch.
• RSI 63.5 — firm, not overbought. MACD +1.72 — the only positive MACD in this batch.
• Maximum drawdown from the six-year peak: −11.9%, implying a peak near $269.
• Relative performance: 3-month +7.2% vs SPY +7.6%; 6-month +1.8% vs SPY +11.1%; 12-month +6.9% vs SPY +24.3% and QQQ +30.8%. Boeing has underperformed the index by seventeen points over twelve months despite a 34.5% revenue increase and a $14.6B free-cash-flow swing — which tells you how much bad news was in the 2024 price and how much good news is in this one.
• Sentiment: 0 strong buy, 37 buy, 13 hold, 5 sell across 55 analysts. Consensus target $274.17 (+15.6%), median $270, high $300 (+26.5%), low $250 — 5.4% ABOVE spot. Not one published target sits below the current price, which is a crowded configuration and the opposite of a contrarian setup.

Today's move

BA closed 2026-08-04 at $237.14, up 1.56% or $3.65 from $233.49, on 6.47M shares in a $232.88-$238.17 range. Modest, in line with a firm broad market. No company-specific news is in this file for 2026-08-04; the last company event was the 2026-07-28 second-quarter release, seven days earlier, at which EPS missed by $0.42.

The honest read: the chart is the best in this batch and the entry is among the worst. A stock at the 79th percentile of its range, 8% above both moving averages, with positive MACD, unanimous sell-side direction, no dividend, negative asymmetry on our own numbers and a base fair value 3.3% above spot, is a name to want lower. The price that makes this asymmetric is nearer $180 — the 52-week low, which is where it traded within the last twelve months and where our base case would be +36%.

9. Insiders

All eight transactions are director awards of Phantom Stock Units at a price of zero, all filed 2026-07-06 for transactions dated 2026-07-01: Bradley Tilden (383 units), John Richardson (228), Steven Mollenkopf (669), David Joyce (440), Akhil Johri (406) and others, with post-transaction holdings ranging from 1,236 to 14,369 units.

These are routine quarterly director retainer awards. They are not purchases, they are not open-market transactions, and they carry no information. The file contains zero open-market purchases and zero open-market sales by any officer or director.

What is notable is the absence. Boeing's shares have risen 32.4% off their 52-week low and the company has just reported two consecutive quarters of positive operating earnings for the first time in years. Not one insider bought a share on the open market during that recovery, and not one sold either. We report that as neutral and decline to read a signal into it, but a management team genuinely convinced the recovery was underpriced had a year in which to act and did not.

10. Verdict, kill-criteria and flip conditions

Watch.

What is genuinely strong: $715,261M of backlog, up $33.1B in six months, 8.0x annual revenue, with 21% converting through 2027; revenue up 34.5% in 2025; the 737 rate from below 38 to 42 per month with 47 planned; free cash flow from minus $14.398B to roughly breakeven — a $14.6B swing; total debt down $8.2B in six months to $45.9B; corrected net debt of $25.878B, not the screened $43.512B; $10.0B of unused revolver capacity; Spirit AeroSystems reintegrated; Global Services earning an 18.7% clean margin; and a structural position that four independent knowledge-base sources across seven years describe as one of the hardest-to-enter industries in the world.

What we are declining to pay for: trailing operating income of minus $5,083M and interest coverage of minus 1.98x; a 2025 profit that is $9,566M of divestiture gain on a business that lost $5.3B from operations; FY2026 consensus EPS still NEGATIVE at minus $0.83; a stock at 30x the FY2028 consensus with a 2.5x consensus spread on that number; $88,388M of inventory, 94% of revenue; total equity of $6,115M, 3.7% of assets; $5,750M of preferred ranking ahead of the common; 39% share dilution since 2020 and no dividend or buyback; a 777-9 first delivery already at 2027 with a disclosed engine durability issue; and a base fair value of $245 that is 3.3% above spot, 10.6% below the street, and produces NEGATIVE asymmetry.

The distinction that matters. We are not saying Boeing fails. The recovery is real, filing-verified, and the balance sheet is far sounder than any screen shows. We are saying that at $237.14, after a 32% run off the low, with every published sell-side target above the price and our own arithmetic producing 0.89:1 asymmetry, the entry has no margin in it. In the Synthos frame, a name where our fair value sits at spot, below consensus, with negative asymmetry and a knowledge-base lane that does not resolve, is a Watch by construction — and one where the wanted price is specific and well below the market.

Pre-registered KILL criteria — what would take this to Avoid:

• A new reach-forward loss of $2B or more on the 777X, 767 or any BDS fixed-price development programme. The 10-K's disclosed engine durability issue is the live trigger and the September 2025 quarter is the precedent.
• A further slip in 777-9 first delivery beyond 2027, which would be the fourth material delay on a programme already carrying multi-billion-dollar losses.
• The 737 rate failing to exceed 42 per month during 2026, against the 10-K's stated plan of 47.
• Free cash flow turning materially negative again for two consecutive quarters after reaching breakeven.
• An inventory charge against the $88,388M balance, or a disclosed order cancellation of scale against the $715.3B backlog.

Pre-registered FLIP conditions — what would take this to Buy — Tactical:

• Price at or below approximately $185-190 (roughly 23x FY2028E) with the operational picture intact. This is the single most likely path to a Buy and it is 20% below today's close — inside the range this stock traded five months ago. At $185 the base case is +32% and the asymmetry inverts to roughly 2:1.
• Commercial Airplanes reporting positive segment earnings in any quarter. It lost $7,079M in 2025 and $322M in the June 2026 quarter; crossing zero is the single most important operational event available and it would validate the FY2027 consensus in one line.
• The 737 rate confirmed at 47 per month with no new reach-forward loss.
• A full half of clearly positive free cash flow, which would let the company start addressing the $5,750M preferred and eventually the dividend.
• A China order re-appearing as a disclosed geographic line. Boeing has not reported a separate CHINA revenue line since 2020; the market was $13,764M in 2018.

Where BA fits in the Synthos Framework Portfolio. The aerospace and defence sleeve, at 0% today with a 1-1.5% target on a fill near $185. On batch overlap: BA is uncorrelated with the rest of this batch — it is the only name here whose earnings are a function of a certification authority and a production rate rather than of demand. Its nearest neighbour in risk profile is nothing in this batch; the honest comparison is to the defence primes in the vendor's own peer set (RTX, LMT, GD, NOC), all of which are profitable and none of which carries Boeing's commercial exposure or its optionality. Logged as a tracked Synthos call (Watch) as of 2026-08-04 at $237.14.

Single biggest risk: another reach-forward loss. Under program accounting, a change in the estimated lifetime cost of a programme is recognised in full, immediately. The 777X and 767 cost $4,079M in 2024 and more again in 2025. The 10-K discloses that a potential engine durability issue was identified in recent 777X inspections and that root cause is still being determined with the supplier. The September 2025 quarter — minus $7.47 EPS against a minus $5.16 estimate — is exactly what that event looks like when it lands. At 30x FY2028 consensus earnings, with negative trailing operating income and no dividend to hold the stock, there is nothing in the valuation to absorb one.

Most fragile assumption in the price: that Commercial Airplanes crosses breakeven by FY2027. Every other assumption is a rate or a backlog assumption, and both are observable monthly. This one requires a segment that lost $7,079M in 2025 and $885M in the first half of 2026 to swing several billion dollars into profit within eighteen months, while cost of sales is rising as a percentage of revenue (90.2% in the June quarter against 89.3%), while the highest-margin service asset has just been sold, and while a new aircraft programme carries an unresolved engine issue. If BCA reaches only breakeven rather than profitability, FY2028 EPS is nearer the $5.118 consensus low than the $7.925 mean, and at 30x that is $150 — the bear case, reached without any change in market sentiment at all.

Provenance & disclosures

• Traceability: 35 raw knowledge-base hits (19 entity, 16 text); 17 used; 18 discarded. Discard reasons, itemised: 8 for SCALE METAPHOR or incidental example ("Boeing-scale revenue", "a leased Boeing 747", "Nokia, Tiffany, Boeing, Viagra", "like Boeing not a plane", and four others); 5 ABOUT A DIFFERENT COMPANY (GE/CFM engine economics, Ryanair's purchasing, Motorola Solutions, and an Airbus-positive claim tagged to EADSY); 2 MACRO DATA ARTEFACT (the 2024 strike as a payrolls distortion); 3 SUPERSEDED (pre-2020 claims about China as Boeing's second-largest market, superseded by Boeing's own removal of the CHINA line from its geographic disclosure after 2020 — noted as informative and excluded from the count). Homograph check on the entity tag "BA" — PASSED: every tagged claim was verified against its thesis text and all are unambiguously about The Boeing Company; no British Airways collision and no ordinary-language collision. Of the 17 used, 6 carry a named speaker — John Ostrower (independent, 2× on 2023-11-07), Richard Abulafia (independent, 2024-12-30), Jim Bianco (skill 0.8, 2026-04-22), Arthur Hayes (skill 1.2, 2026-04-22) and Graham Allison (2026-05-14) — and 11 are channel-attributed with no named speaker. A further claim from Mark Benioff (2026-05-15) is a corporate chief executive forecasting political order books; it and the four other political-order claims are weighted LOW with the frame disclosed. No Boeing management voice appears anywhere in the lane, so the half-weight management discount does not apply. Net conviction mixed, breadth 17 — the lane contains a five-claim durable-duopoly case and a four-claim structural-decline case, and it does not resolve. We record one dated miss: a 2024-05-12 claim rating Boeing default "a decent risk scenario" is clearly wrong against the current balance sheet. Searches: Boeing, Airbus, Ortberg. All quotes are verbatim from the stored claim text.
• Data as-of: fundamentals — annual statements to 2025-12-31 from the vendor payload; quarterly income statement to 2026-06-30; most recent filing-verified financials 2026-06-30, from the 10-Q filed 2026-07-28 · estimates 2026-08-04 · prices 2026-08-04, quote timestamp 1785873598 = 2026-08-04T20:00:00Z ($237.14, +1.56%; 50-DMA $219.48; 200-DMA $218.59; RSI 63.5; MACD +1.72) · knowledge-base claims 2026-08-04. Fiscal note: Boeing's fiscal year is the calendar year. All figures come from the Synthos vendor data file for BA or from the SEC filings in the BA archive; no figure comes from memory, recall or external retrieval.
• Filing archive contents: 10-K filed 2026-01-30 (fiscal 2025); 10-Q filed 2026-04-22 (March 2026 quarter); 10-Q filed 2026-07-28 (June 2026 quarter); 8-K filed 2026-04-17; 8-K filed 2026-04-22; 8-K filed 2026-07-28 (second-quarter results). All six carry preserved financial tables (tables: true), which is why the balance sheet, segment table, backlog table and cost-of-sales analysis in this dive are filing-sourced.
• Where the filings contradicted or corrected the vendor (detailed in Section 7): net debt rebuilt from the vendor's $43,512M to $25,878M — a 68% overstatement produced by ignoring $12,783M of short-term investments and carrying a six-month-old balance sheet across $8.2B of debt reduction, with the 10-Q stating "the total debt balance was $45.9 billion, down from $54.1 billion at December 31, 2025"; enterprise value rebuilt from $226.079B to $219.071B including $5,750M of 6.00% Series A mandatory convertible preferred stock that appears in no vendor field; seg_prod for fiscal 2025 rejected outright for containing one segment ($41,494M of Commercial Airplanes) out of three, with Defense, Space & Security ($27,234M) and Global Services ($20,923M) absent, and replaced with the 10-K's table which ties exactly to $89,463M; seg_geo corrected for a 1.44x double-count (a Non-US subtotal reported alongside its own six components plus the US line, summing to $129.26B against $89.463B of revenue); FY2025 operating income reconciled between the filing's $4,281M and the vendor's minus $5,416M, with the $9,566M Digital Aviation Solutions divestiture gain identified as the entire bridge and the ex-gain figure of roughly minus $5.3B used for all trend work; est.ebitdaAvg rejected as arithmetically impossible (negative in every forward year against positive net income, at a fixed minus 0.2604% of revenue in all eight years); all trailing earnings, EBITDA, P/E, EV/EBITDA, price-to-free-cash-flow and interest-coverage metrics rejected as artefacts of the one-off gain and near-zero cash flow; all book-equity metrics rejected on total equity of $6,115M that was negative eighteen months ago; the vendor's internal $4.86B enterprise-value inconsistency recorded; lastDividend: 8.22 contradicted by dividendPerShareTTM: 0 in the same payload and resolved to zero (Boeing suspended its dividend in 2020); and Q2 2026 operating income taken from the 10-Q's $156M rather than the vendor's $78M. Where vendor and filing AGREED — worth recording: the share count (10-Q's 1,012,261,159 issued less 222,468,625 treasury = 789,792,534, matching the implied market-cap count to 0.07%); FY2024 and FY2023 operating income to within 1%; Q2 2026 revenue of $24,560M and Q1 2026 operating income of $448M exactly; and the cash and short-term investment balances.
• Basis note: est.epsAvg is a core (non-GAAP) EPS measure. The earn_cal actuals (minus $1.24, minus $7.47, $9.92, minus $0.20, minus $0.76) differ from GAAP diluted EPS (minus $0.92, minus $7.14, $10.23, minus $0.11, minus $0.67) in every quarter, so the two series are distinct. Both are contaminated by the fourth-quarter 2025 divestiture gain, which flows through both GAAP ($10.23) and core ($9.92) EPS. We therefore run no trailing multiple of any kind and anchor entirely on FY2028 and FY2029 forward consensus, disclosing analyst counts at every point of use.
• Estimate coverage: 13 analysts on FY2026 EPS and 17 on revenue; 16 and 19 on FY2027; 13 and 20 on FY2028; 11 and 11 on FY2029; 5 and 11 on FY2030 — FY2030 is excluded. The FY2028 EPS row, which anchors all three fair values, carries 13 analysts and a $5.118-to-$12.617 range — a factor of 2.5 — and that dispersion is disclosed at every point of use because it is more informative than the mean.
• Peer note: the vendor peer set mixes genuine defence primes (RTX $293.5B, Lockheed Martin $136.0B, General Dynamics $104.4B, Northrop Grumman $78.4B, L3Harris $53.1B) with non-comparables (Eaton, Honeywell, Union Pacific) and sub-$4B micro-caps (Firefly Aerospace, Voyager Technologies). Boeing's only true comparable, Airbus, is not in the payload. No peer multiples are supplied, so no peer-multiple comparison is drawn.
• Fair-value caveat: the $150 / $245 / $315 anchors are multiples of the FY2028 consensus EPS distribution — 29.3x the low of $5.118, 30.9x the mean of $7.925, and 25x the high of $12.617. Stated arithmetic, not a discounted cash flow. Note the deliberate construction: the bear case applies TODAY'S multiple to a worse number, so it requires only a slower recovery and no loss of market faith; the bull case applies a LOWER multiple to a better number. The base is sensitivity-disclosed: 25x FY2028E gives $198, sixteen percent BELOW spot; 35x gives $277. The whole answer lives in a 25-35x band on a consensus number with a 2.5x spread, and no greater precision is claimed. Our base of $245 is 10.6% below the street mean of $274.17 and 2.0% below the street's most bearish published target of $250 — we are more cautious than the entire published sell-side and state that plainly.
• Timing: second-quarter 2026 results were released 2026-07-28, seven days before this dive, with EPS missing consensus by $0.42 (minus $0.76 against minus $0.34) and revenue beating by 1.2% ($24,560M against $24,264M). The next print is 2026-10-28, 85 days away. There is no near-term company-specific catalyst, which is an explicit input to the Watch verdict. 2026-08-04 was a firm broad-market session; BA's +1.56% carried no company-specific news in this file.
• Accessibility note: no information in this dive is conveyed by colour. All emphasis is carried by bold text, table structure and explicit labelling.
• Not investment advice. Independent research, educational and informational only, never personalised. No recommendation to buy, sell or hold any security is made to any person.
• Version: 2026-08-04-full.